gentamicin has been researched along with telavancin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA | 1 |
Gandhi, RG; Leonard, SN; Patel, MD; Supple, ME | 1 |
3 other study(ies) available for gentamicin and telavancin
Article | Year |
---|---|
Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Topics: Aminoglycosides; Gentamicins; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus; Vancomycin | 2009 |
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors | 2010 |
Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Nafcillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2013 |